Nucs Ai

About Nucs Ai

Nucs AI is revolutionizing cancer care through cutting-edge AI and medical imaging technology. Founded in 2024, the company combines oncologists, AI researchers, and healthcare innovators to address the growing demand for accurate, timely cancer diagnostics amid rising scan volumes and limited radiologist capacity. They develop AI-powered tools at the convergence of medical imaging, radioligand therapy, and artificial intelligence, with initial focus on prostate cancer and expansion across oncology. Nucs AI partners with world-leading medical institutions and pharmaceutical companies across the US, Europe, and Australia to bring precision oncology into everyday clinical practice. Their mission is to enhance diagnostic precision and expand access to expert-level cancer care, improving patient outcomes worldwide.